Stock Information

• Merck’s KEYTRUDA Combo Wins and Pipeline Shuffle Might Change The Case For Investing In Merck (MRK)
  Wed, Mar 4, 2026 6:11 AM
• DHS: Dividend ETF With Balanced Portfolio, But Average Results
  Wed, Mar 4, 2026 6:00 AM
• Most Retirees Overlook These Dow Dividend Stocks — They Pay More Than You’d Expect
  Tue, Mar 3, 2026 5:49 PM
• Merck & Co., Inc. (MRK) Presents at TD Cowen 46th Annual Health Care Conference Transcript
  Tue, Mar 3, 2026 3:42 PM
• Merck's Keytruda Drives its 2025 Revenue Surge: What's Ahead?
  Tue, Mar 3, 2026 3:05 PM
• Tempus Announces Strategic Collaboration Agreement with Merck to Accelerate AI-Driven Precision Medicine
  Tue, Mar 3, 2026 1:30 PM
• MXene Industry Research Report 2026: Market to Grow at a CAGR of 35.6% to 2032, Driven by EV & Charging Infrastructure, Water Treatment Applications and High-Performance Aerospace & Defense Systems
  Tue, Mar 3, 2026 9:53 AM
• AI in Pharma Manufacturing Market Research 2026-2040: Pfizer, Moderna, Novartis, Merck, and Sanofi are Integrating AI Into Their Operations As the Sector Evolves Towards Pharma 4.0
  Tue, Mar 3, 2026 9:24 AM
• Merck (MRK) Stock Dips While Market Gains: Key Facts
  Mon, Mar 2, 2026 10:45 PM
• Merck Keytruda Combos Strengthen Oncology Platform And Raise Patent Questions
  Mon, Mar 2, 2026 8:14 PM

Financial data not available